Guidelines for Echocardiography

Diseases

Methodology

• Valvular Heart Disease – 2021 ESC
• Valvular Heart Disease – 2020 AHA-ACC
• Mitral regurgitation – 2020 ACC
• HFpEF – 2020 ESC
• LAA Occlusion – 2020 EHRA
• POCUS – 2020 ASE
• ARVC – 2019 ESC
• Acute PE – 2019 ESC
• Adult with CHD – 2018 EACVI
• Right heart dysfunction & failure in HFpEF – 2018 ESC
• Patent Forament Ovale – 2018 ESC
• Right heart dysfunction in HFpEF – 2017 ESC
• Athletes’s heart – 2017 EACVI
• Subclinical organ damage in hypertension – 2017 EACVI
• Cardiac sarcoidosis – 2017 EACVI
• Aortic valve stenosis – 2017 EACVI
• Restrictive cardiomyopathies – 2017 EACVI
• Arrhythmogenic cardiomyopathy – 2017 EACVI
• Use of CVS imaging in heart valve diseases – 2017 EACVI
• Multimodality imaging in valvular heart disease – 2017 ASE-ACC-AHA
• Native valvular regurgitation – 2017 ASE
• Treatment appropriate criteria for AS – ASE-ACC-AHA
• Use of CVS imaging in HF – 2016 EACVI
• Prosthetic heart valves – 2016 EACVI
• Severe peripartum cardiomyopathy – 2016 ESC
• Diagnosis & treatment of PH – 2016 ESC
• Acute right ventricular failure – 2016 ESC
• Atrial cardiomyopathies – 2016 EHRA
• Ischemic mitral regurgitation – 2016 AATS
• Management & treatment od pericardial diseases – 2015 ESC
• Use of echocardiography in adult hypertension – 2015 EACVI-ASE
• Echocardiography to manage LVAD – 2015 ASE
• Management infective endocarditis – 2015 ESC
• Multimodality imaging in HCM – 2015 EACVI
• Multimodality imaging in pericardial diseases – 2015 EACVI
• Multimodality imaging in athlete’s s heart – 2015 EACVI
• Multimodality imaging for thoracic aorta disease – 2015 EACVI-ASE
• Assessment of PFO – 2015 ASE
• Infective endocarditis in adults – 2015 AHA
• Adult and cancer therapy – 2014 EACVI-ASE
• Chronic systolic heart failure – 2014 EACVI

• TT Echocardiography – 2019 ASE
• TEE chidren & CHD – 2019 ASE
• Stress echocardiography in IHD – 2019 ASE
• Multimodality imaging for cardiac structure and function- 2019 ASE
• Handheld devices – 2018 EACVI
• Ultrasonic enhancing agents – 2018 ASE
• Use of noninvasive hemodynamics – 2017 SCAI
• Standardization of reporting – 2017 EACVI
• Contrast echocardiography – 2017 EACVI
• Appropriateness criteria for TT echocardiography – 2017 EACVI
• Defining quality in CVS imaging – 2017 AHA
• Stress echocardiography in non-IHD – 2016 EACVI-ASE
• LV diastolic function – 2016 EACVI-ASE
• COCATS Task Force 5 training in echocardiography – 2015 ASE
• Common standard for 2D speckle tracking – 2015 EACVI-ASE
• Use of echocardiography in acute CVS care – 2015 EACVI
• Cardiac chamber quantification – 2015 EACVI-ASE
• Echocardiography to monitor therapeutic interventions – 2015 ASE
• Standards for laboratory accreditation – 2014 EACVI
• Recommendations for TEE – 2014 EACVI